Protection by group II phospholipase A2 against Staphylococcus aureus.
about
Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureusThe secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice.Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionAccelerated calcium influx and hyperactivation of neutrophils in chronic granulomatous diseaseCharacterization of serum phospholipase a(2) activity in three diverse species of west african crocodilesEdema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages.Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis.Physiological roles of group X-secreted phospholipase A2 in reproduction, gastrointestinal phospholipid digestion, and neuronal function.Parenteral nutrition decreases paneth cell function and intestinal bactericidal activity while increasing susceptibility to bacterial enteroinvasionIntegrated lipidomics in the secreted phospholipase A(2) biology.Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessmentLipidome and transcriptome profiling of pneumolysin intoxication identifies networks involved in statin-conferred protection of airway epithelial cells.A new era of secreted phospholipase A₂Route and type of nutrition and surgical stress influence secretory phospholipase A2 secretion of the murine small intestine.Multiple roles of phospholipase A2 during lung infection and inflammation.Differential expression of decorin by human malignant and benign vascular tumors.IL-25 improves luminal innate immunity and barrier function during parenteral nutrition.Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammationNutrition and gut immunity.Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection.Antibacterial properties of chicken intestinal phospholipase A2.Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3
P2860
Q24293487-251FAE8C-7143-42B0-81C5-30C23E587D6CQ24317652-BE21B8DA-81E1-41BA-979D-ED65CDECE1B9Q24631144-A1D101F9-6F8D-4BA8-B1F6-7F94072EE467Q26997377-8F2448EC-A449-4639-96FC-46DD594EE2DCQ28350996-59469F30-E3CD-4817-B662-2354DD9D9902Q28743289-ABA40031-20BC-4353-BDE6-BF29631C5696Q33309460-C65E27E6-2124-4C2F-99B0-08A44D688688Q34415813-0437151E-F6D5-4EEA-82DB-83A17FA05247Q34719758-878C593D-78A3-4BAD-97FE-BCF75E687174Q34872081-894ECD69-DC01-4A6F-8F2E-1AFCC91D395FQ35036028-7832981A-34E4-4EB7-8B28-F01384AC8CF0Q35542696-B2C0443E-EA81-4037-9B9A-3078F1263BABQ35663656-44BDDBA4-1137-4EF4-A7B8-F2AD792F3901Q35776615-B37BD39A-040D-4335-868F-5DCF0D4C0D9AQ35927426-207CB857-C495-40AC-9891-A285AA28347FQ36710691-EC3AF0FE-F9E3-486F-9A19-B6383C050E56Q36725204-D34900A5-7B0D-40DA-B8A2-764DF4E37EF3Q36867732-6E15B9C8-5AE9-4903-A00E-A2D922DBBDF7Q37257483-7D594FAF-A0FE-4CDD-B75C-56FA06E0C38FQ37905284-E0BB022E-3007-4239-B5F4-775FE3E2BE82Q39513604-84770104-BB07-4465-84EF-8E7C4EEBC803Q42043929-B25C325D-9181-47AE-A9F3-FD5BFF07878DQ42730621-0288690F-063F-4BFA-BBA8-5F5A5D23EB28
P2860
Protection by group II phospholipase A2 against Staphylococcus aureus.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Protection by group II phospholipase A2 against Staphylococcus aureus.
@en
Protection by group II phospholipase A2 against Staphylococcus aureus.
@nl
type
label
Protection by group II phospholipase A2 against Staphylococcus aureus.
@en
Protection by group II phospholipase A2 against Staphylococcus aureus.
@nl
prefLabel
Protection by group II phospholipase A2 against Staphylococcus aureus.
@en
Protection by group II phospholipase A2 against Staphylococcus aureus.
@nl
P2093
P921
P1476
Protection by group II phospholipase A2 against Staphylococcus aureus.
@en
P2093
T J Nevalainen
P304
P407
P577
1999-06-01T00:00:00Z